Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,180 | -3,595 | -1,308 | 825 | -5,495 |
| Depreciation Amortization | 357 | 269 | 182 | 91 | 363 |
| Other Working Capital | 274 | 196 | 207 | -12 | -266 |
| Other Operating Activity | -2,732 | -2,804 | -2,800 | -2,722 | -2,815 |
| Operating Cash Flow | $-8,282 | $-5,934 | $-3,720 | $-1,818 | $-8,213 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -72 | -5 | -4 | N/A | -59 |
| Investing Cash Flow | $-72 | $-5 | $-4 | $N/A | $-59 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -246 | -184 | -123 | -61 | -123 |
| Common Stock Issued | 13,016 | 8,024 | 8,024 | N/A | 3,300 |
| Other Financing Activity | 3,172 | -113 | -113 | -70 | -471 |
| Financing Cash Flow | $15,941 | $7,727 | $7,789 | $-131 | $2,707 |
| Beginning Cash Position | 3,913 | 3,858 | 3,858 | 3,858 | 9,423 |
| End Cash Position | 11,500 | 5,646 | 7,922 | 1,908 | 3,858 |
| Net Cash Flow | $7,587 | $1,788 | $4,064 | $-1,949 | $-5,565 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,282 | -5,934 | -3,720 | -1,818 | -8,213 |
| Capital Expenditure | -72 | -5 | -4 | N/A | -59 |
| Free Cash Flow | -8,355 | -5,939 | -3,724 | -1,818 | -8,272 |